Corporate ActionJul 7, 2026, 12:51 PM
Cuprina Holdings Files F-1 for Public Offering of Class A Ordinary Shares
AI Summary
Cuprina Holdings (Cayman) Limited filed an F-1 registration statement for a public offering of its Class A Ordinary Shares on Nasdaq. The Singapore-based biomedical and biotechnology company, which develops chronic wound care and cosmeceutical products, reported a net loss of US$3.63 million on revenue of US$38,789 for the year ended December 31, 2025. The company is an emerging growth company and a foreign private issuer, planning to use the proceeds for supply chain expansion, marketing, and working capital.
Key Highlights
- Public offering of Class A Ordinary Shares on Nasdaq.
- Net loss of US$3.63 million for the year ended December 31, 2025.
- Revenue of US$38,789 for the year ended December 31, 2025.
- Underwriters to receive warrants for 4.0% of shares sold.
- Class B Ordinary Shares carry 100 votes each, Class A carry 1 vote.
- Company to remain a "controlled company" post-offering.
- Proceeds to be used for supply chain, marketing, and working capital.
Price Impact
More from CUPR